Cronos Group/$CRON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cronos Group
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Ticker
$CRON
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Stayner, Canada
Employees
459
ISIN
CA22717L1013
Website
Cronos Group Metrics
BasicAdvanced
$803M
17.74
$0.12
1.53
-
Price and volume
Market cap
$803M
Beta
1.53
52-week high
$2.54
52-week low
$1.60
Average daily volume
1.5M
Financial strength
Current ratio
27.795
Quick ratio
26.29
Long term debt to equity
0.075
Total debt to equity
0.163
Profitability
EBITDA (TTM)
-34.56
Gross margin (TTM)
31.89%
Net profit margin (TTM)
39.68%
Operating margin (TTM)
-35.23%
Effective tax rate (TTM)
-7.11%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
-2.42%
Return on equity (TTM)
4.59%
Valuation
Price to earnings (TTM)
17.744
Price to revenue (TTM)
6.385
Price to book
1.03
Price to tangible book (TTM)
1.11
Price to free cash flow (TTM)
-105.151
Free cash flow yield (TTM)
-0.95%
Free cash flow per share (TTM)
-1.98%
Growth
Revenue change (TTM)
33.92%
Earnings per share change (TTM)
-186.40%
3-year revenue growth (CAGR)
13.80%
10-year revenue growth (CAGR)
73.23%
3-year earnings per share growth (CAGR)
-43.50%
10-year earnings per share growth (CAGR)
2.43%
What the Analysts think about Cronos Group
Analyst ratings (Buy, Hold, Sell) for Cronos Group stock.
Bulls say / Bears say
Jefferies raised Cronos Group's stock target to C$3.23, citing potential positive scenarios such as entering the U.S. market, a merger with a more optimistic company, or additional investment from Altria Group. (Investing.com)
Cronos Group's 'Spinach' brand became the No. 1 recreational cannabis brand in Canada, and its 'Peace Naturals' brand leads the medical marijuana market in Israel, indicating strong market positions. (Nasdaq)
The Department of Health and Human Services proposed reclassifying marijuana to a lower-risk drug category, potentially benefiting companies like Cronos Group. (Markets Insider)
Jefferies maintained a Hold rating on Cronos Group, noting that current operations are not generating significant value and future prospects appear challenging. (Investing.com)
Cronos Group posted a net loss of $8.7 million in its latest quarter, indicating ongoing profitability challenges. (The Motley Fool)
The U.S. Drug Enforcement Administration delayed a public meeting about rescheduling cannabis until after the presidential election, raising concerns about potential delays in U.S. market entry for companies like Cronos Group. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Cronos Group Financial Performance
Revenues and expenses
Cronos Group Earnings Performance
Company profitability
Cronos Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cronos Group stock?
Cronos Group (CRON) has a market cap of $803M as of July 10, 2025.
What is the P/E ratio for Cronos Group stock?
The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 17.74 as of July 10, 2025.
Does Cronos Group stock pay dividends?
No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of July 10, 2025.
When is the next Cronos Group dividend payment date?
Cronos Group (CRON) stock does not pay dividends to its shareholders.
What is the beta indicator for Cronos Group?
Cronos Group (CRON) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.